Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Celularity ( (CELU) ) has issued an update.
On January 23, 2025, Celularity Inc. announced that its securities purchase agreement with an institutional investor expired due to non-receipt of the subscription amount, resulting in the cancellation of its planned private placement for common stock and warrants. This development may impact the company’s fundraising efforts and its financial strategy moving forward.
More about Celularity
Celularity Inc. operates in the biotechnology industry, focusing on developing cell therapies from placental-derived cells to treat cancer, infectious, and degenerative diseases.
YTD Price Performance: 4.55%
Average Trading Volume: 1,166,772
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $51.71M
See more data about CELU stock on TipRanks’ Stock Analysis page.
